Literature DB >> 3872794

Evidence for nonspecific induction of beta-lactamase in overproducing variants of Enterobacter cloacae and Citrobacter freundii.

W Cullmann, W Dick.   

Abstract

Induction of chromosomally mediated beta-lactamases was studied in clinical isolates of Enterobacter cloacae and Citrobacter freundii. Whereas isolates resistant to ampicillin and cefoxitin exhibited an inducible enzyme, those sensitive to both agents did not. Cefoxitin and above all imipenem proved the most efficacious enzyme inducers. Variants among these inducible isolates which produced large amounts of beta-lactamase could be selected in the presence of cefamandole. In each of these selected variants constitutive enzyme production was markedly enhanced by induction, even with compounds lacking induction potency for the corresponding wild strains. Moreover, these variants could also be induced non-specifically, i.e. by non-beta-lactam compounds. Production of large amounts of enzyme was associated with resistance to all available beta-lactam compounds.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872794     DOI: 10.1007/bf02148657

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  15 in total

1.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

2.  Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.

Authors:  C C Sanders
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

3.  The classification and terminology of enzymes that hydrolyze beta-lactam antibiotics.

Authors:  R B Sykes
Journal:  J Infect Dis       Date:  1982-05       Impact factor: 5.226

4.  Resistance to cefamandole: derepression of beta-lactamases by cefoxitin and mutation in Enterobacter cloacae.

Authors:  T D Gootz; C C Sanders; R V Goering
Journal:  J Infect Dis       Date:  1982-07       Impact factor: 5.226

5.  Correlation of beta-lactamase production and resistance to beta-lactam antibiotics in Enterobacteriaceae.

Authors:  W Cullmann; T Flensberg; W Opferkuch; M Stieglitz; B Wiedemann
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1982-09

6.  Investigations on beta-lactamase stability of recently developed beta-lactam compounds: study of enzyme kinetics.

Authors:  W Cullmann; W Dick
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1983-05

7.  Specificity of beta-lactamase induction in Pseudomonas aeruginosa.

Authors:  A Dalhoff; W Cullmann
Journal:  J Antimicrob Chemother       Date:  1984-10       Impact factor: 5.790

8.  Properties of Ro 13-99041 as a substrate and inhibitor of beta-lactamases.

Authors:  R L Then
Journal:  Chemotherapy       Date:  1981       Impact factor: 2.544

9.  Escherichia coli K-12 mutants hyperproducing chromosomal beta-lactamase by gene repetitions.

Authors:  S Normark; T Edlund; T Grundström; S Bergström; H Wolf-Watz
Journal:  J Bacteriol       Date:  1977-12       Impact factor: 3.490

10.  Nonspecific induction of beta-lactamase in Enterobacter cloacae.

Authors:  W Cullmann; A Dalhoff; W Dick
Journal:  J Gen Microbiol       Date:  1984-07
View more
  4 in total

1.  Incidence of inducible beta-lactamases in gram-negative septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance.

Authors: 
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

2.  Ability of newer beta-lactam antibiotics to induce beta-lactamase production in Enterobacter cloacae.

Authors:  R L Then
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

3.  Selection and properties of Pseudomonas aeruginosa variants resistant to beta-lactam antibiotics.

Authors:  W Cullman; K H Büscher; W Dick
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

Review 4.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.